Document is current

Article History

Received: 9 September 2023

Accepted: 3 April 2024

First Online: 29 April 2024

Declarations

:

: This study was approved by the Institutional Ethics Review Board of the Third People’s Hospital of Chengdu (record #:2018S75; Chengdu, Sichuan, China), and was conducted in accordance with the Chinese ethical guidelines for human genome/gene research. informed consent/waiver of informed consent (Institutional Ethics Review Board of the Third People’s Hospital of Chengdu) was obtained from all subjects and/or their legal guardian(s).

: Not applicable.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.